Hiroshi Yotsuyanagi

机构：National Institute of Infectious Diseases, Institute for Security Studies, University of Tokyo Hospital, Institute for Advanced Medical Research, Institute for Health Economics and Policy, Advanced Medical Research Institute, The University of Tokyo · ORCID：0000-0001-7882-5262

发表论文 388 篇 · 总被引 9569 次 · h-index 51

代表论文

• Ensitrelvir treatment–emergent amino acid substitutions in SARS-CoV-2 3CLpro detected in the SCORPIO-SR phase 3 trial (2025 · Antiviral Research · 被引 8)
• Epidemic of multiple Treponema pallidum strains in men who have sex with men in Japan: efficient multi-locus sequence typing scheme and indicator biomarkers (2024 · AIDS Research and Therapy · 被引 6)
• MicroRNA in neuroexosome as a potential biomarker for HIV-associated neurocognitive disorders (2025 · Journal of NeuroVirology · 被引 4)
• Prediction of intrahepatic covalently closed circular DNA levels in patients with resolved hepatitis B virus infection: Impact of serum antibody to hepatitis B core antigen titers (2024 · Hepatology Research · 被引 4)
• Ensitrelvir as a novel treatment option for mild-to-moderate COVID-19: a narrative literature review (2025 · Therapeutic Advances in Infectious Disease · 被引 3)
• Sexually Transmitted Treponema pallidum Subspecies endemicum Infection With Atypical Skin Manifestations Outside of Tropical Regions (2024 · Open Forum Infectious Diseases · 被引 2)